In exclusive written Q&A with Science|Business, EU commissioner for research, innovation, education and youth vows hundreds of millions for coronavirus R&D but calls on member states to agree on the multiannual budget to avoid delaying critical research.
The European Commission’s R&D toolbox in the COVID-19 outbreak includes extended deadlines in Horizon 2020, additional funding opportunities for viral research - and less red tape
EU president Charles Michel says there is ‘strong common will’ between G7 countries to deliver coronavirus vaccine, following reports of big-money overture by president Trump to CureVac
Brussels outlines broad cooperation with UK in nuclear research, renewable energy and antimicrobial resistance, and suggests visa waivers for short-term researcher visits
Early stage human trials for vaccine against the virus are ‘days or weeks’ away, but it will take at least 12 – 18 months to complete safety and efficacy tests, and much more money is needed
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.